Outset Medical, Inc. (OM)
NASDAQ:OM
Want to see OM full AI Analyst Report?
Earnings Data
Report Date
Aug 05, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.72Last Year’s EPS
-0.84Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a largely positive operational and financial trajectory: substantial gross margin expansion (620 bps), a 32% improvement in non-GAAP net loss, strong cash balance ($161M) with lower-than-expected cash burn, and a strategic next-generation product and experienced commercial hire poised to drive future demand. Offsetting these positives were a 6% year-over-year revenue decline in Q1 driven by lumpiness in capital orders (product revenue down 13%), modestly higher operating expenses, and reliance on the timing and success of the next-gen Tableau launch to deliver back-half revenue. On balance, the positive margin, cash, and operational execution updates outweigh the timing-related revenue headwinds.Company Guidance
Revenue and Guidance Reaffirmed
Q1 revenue of $27.9M and company reaffirmed 2026 revenue guidance of $125M–$130M (a 5%–9% increase over 2025), with majority of growth expected in Q3–Q4.
Recurring Revenue Stability
Recurring revenue (consumables and service) of $22.5M was roughly flat sequentially and year-over-year, representing ~70% of total revenue and providing a predictable revenue base.
Strong Gross Margin Expansion
Non-GAAP gross margin expanded by 620 basis points year-over-year to 43.8%. Product gross margin rose to 52.4% (up 400 bps from 48.4%), and service gross margin improved to 26.7% (up ~1,600 bps from 10.3%).
Progress Toward Profitability
Non-GAAP net loss improved 32% year-over-year to $15.4M (from $22.8M), while non-GAAP operating loss remained steady at $13.4M, reflecting margin expansion and disciplined spending.
Strong Cash Position and Lower Cash Burn
Ended Q1 with $161M in cash, equivalents and short-term investments, used ~$12M in the quarter and now expect full-year cash usage to be below $40M (approximately 15% better than prior forecast).
Next-Generation Tableau Launch
Planned limited release this quarter and full ramp into Q3; positioned as the first dialysis system cleared under FDA 2025 cybersecurity requirements, expected to be a competitive demand driver.
Commercial Leadership and Execution Wins
Hired Derek Elliott as EVP of Commercial; multiple go-live implementations including a recent deployment across hospitals in a ~400-bed system and planned Q2 go-lives at 30+ facilities involving nearly 200 consoles.
Scale and Data Advantages
More than 1,000 facilities using Tableau, over 3.5M cumulative treatments, and >8 trillion data points in cloud platform to fuel analytics, product innovation, and customer value.
OM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
OM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | $4.68 | $3.69 | -21.05% |
Feb 11, 2026 | $4.54 | $3.80 | -16.30% |
Nov 10, 2025 | $12.07 | $6.22 | -48.47% |
Aug 06, 2025 | $13.17 | $14.18 | +7.67% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Outset Medical, Inc. (OM) report earnings?
Outset Medical, Inc. (OM) is schdueled to report earning on Aug 05, 2026, After Close (Confirmed).
What is Outset Medical, Inc. (OM) earnings time?
Outset Medical, Inc. (OM) earnings time is at Aug 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OM EPS forecast?
OM EPS forecast for the fiscal quarter 2026 (Q2) is -0.72.